Element Fleet Management and Motus have launched a strategic collaboration to deliver comprehensive solutions for all drivers.

The Place community marketplace is now officially open, bringing the first permanent, collective shopping experience to the ...

The developer Dominium has recently acquired sites in three Phoenix suburbs and plans to create more than 750 affordable ...

Learn insights from Madrigal Pharmaceuticals' Q2 2025 earnings: Rezdiffra's growth, new patent till 2045, global expansion, and pipeline advances.

WEST CONSHOHOCKEN, Pa. (AP) — WEST CONSHOHOCKEN, Pa. (AP) — Madrigal Pharmaceuticals Inc. (MDGL) on Tuesday reported a loss of $42.3 million in its second quarter. The West Conshohocken, ...

Madrigal Pharmaceuticals secures $500 million credit facility to expand its MASH pipeline and refinance existing debt. Quiver AI Summary Madrigal Pharmaceuticals, Inc. has secured a $500 million ...

Madrigal plans to use the funds primarily to advance its pipeline for metabolic dysfunction-associated steatohepatitis (MASH), according to the company’s statement.

Madrigal undertakes no obligation to update any forward-looking statements to reflect new information, events, or circumstances after the date they are made, or to reflect the occurrence of ...

A $350 million initial term loan funded at closing, a portion of which was used to refinance Madrigal’s existing $115 million senior secured debt plus fees;A $150 million delayed draw term loan ...

Madrigal undertakes no obligation to update any forward-looking statements to reflect new information, events, or circumstances after the date they are made, or to reflect the occurrence of ...

Pharma Madrigal's Rezdiffra, the first-ever MASH drug, beats sales projections for 4 quarters in a row By Angus Liu May 2, 2025 11:00am ...

First-quarter 2025 Rezdiffra™ (resmetirom) net sales of $137.3 million As of March 31, 2025, more than 17,000 patients on Rezdiffra Two-year compensated MASH cirrhosis (F4c) data from MAESTRO ...